J. Ardill

3.2k citations
45 papers · 1.8k indexed · h-index 22

J. Ardill

42 papers receiving 1.7k citations

Peers

J. Ardill
Comparison fields: 5 of 84
  • Gastroenterology 604
  • Neurology 389
  • Oncology 581
  • Epidemiology 662
  • Surgery 811
Replace James R. Upp with:
James R. Upp United States
Claus Hovendal Denmark
G Lombardi Italy
P. C. Ganguli United Kingdom
R. B. Welbourn United Kingdom
G. T. P. Saccone Australia
T. Holmin Sweden
André Wettergren Denmark
W. Niebel Germany
L. Gullo Italy
J. Ardill relative to James R. Upp United States James R. Upp's profile →
Citations per field
00.5×8.9×
James R. Upp · 1×
Citations per year

Countries citing papers authored by J. Ardill

Since Specialization
Citations

This map shows the geographic impact of J. Ardill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ardill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ardill more than expected).

Fields of papers citing papers by J. Ardill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ardill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ardill. The network helps show where J. Ardill may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Ardill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Ardill Line = papers co-authored together J. Ardill links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201515
2 201389
3 2009215
4 20082
5 200697
6 2005130
7
Clinical and biochemical prognostic indicators at diagnosis in 117 midgut carcinoid tumours
20030
8 200371
9 199997
10 199822
11 199732
12
Marked rebound acid hypersecretion after treatment with ranitidine.
199637
13 199522
14 19956
15 199367
16 199216
17 19921
18 19884
19 19845
20 19783

About J. Ardill

J. Ardill is a scholar working on Gastroenterology, Epidemiology, Surgery, Neurology and Oncology, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (17 papers), Gastroesophageal reflux and treatments (16 papers), Helicobacter pylori-related gastroenterology studies (16 papers), Lung Cancer Research Studies (8 papers), Neuroblastoma Research and Treatments (7 papers), Diabetes Treatment and Management (4 papers), Gastrointestinal motility and disorders (3 papers) and Eosinophilic Esophagitis (2 papers). The work is most often cited by research in Gastroenterology (604 citations), Neurology (389 citations), Oncology (581 citations), Epidemiology (662 citations) and Surgery (811 citations). J. Ardill has collaborated with scholars based in United Kingdom, Ireland and Sweden. Frequent co-authors include K E McColl, Emad El‐Omar, Ian Penman, C A Dorrian, Kenneth E.L. McColl, K. D. Buchanan, A A Wirz, R S Chittajallu, W D Neithercut and David R. McCance. Their work appears in journals such as Gut, Scandinavian Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics, Endocrine Related Cancer and QJM.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026